XBiotech Inc.
Price Action
Technical Summary
WEAKENINGXBiotech Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 39), showing significant lag compared to the market leaders. Earnings growth of 50% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.36 | -1.12% | BELOW |
| 50 SMA | $2.44 | -4.35% | BELOW |
| 100 SMA | $2.39 | -2.54% | BELOW |
| 150 SMA | $2.42 | -3.68% | BELOW |
| 200 SMA | $2.46 | -5.25% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is XBIT in an uptrend right now?
XBIT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is XBIT overbought or oversold?
XBIT's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is XBIT outperforming the market?
XBIT has a Relative Strength (RS) Rating of 39 out of 99. XBIT is currently lagging the broader market.
Where is XBIT in its 52-week range?
XBIT is trading at $2.33, which is 65% of its 52-week high ($3.61) and 16% above its 52-week low ($2.09).
How volatile is XBIT?
XBIT has a Beta of 0.74 and 52-week volatility of 49%. It's less volatile than the S&P 500 - generally more stable.